Trial intelligence / Profile preview

Abstinence Reinforcement Therapy for Homeless Veterans Who Smoke

NCT07714200Not yet recruiting

Sponsor
VA Office of Research & Development
Start
Mar 2027
Primary completion
Mar 2030
Countries
1
01

Overview

Randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Bioverified Prolonged Smoking Abstinence at 6 months. Planned start Mar 2027; status: not yet recruiting.

02

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT07714200.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07714200.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call